Poster Presentations
Adjuvant endocrine therapy | ||
P01 | SUSHI DOMAIN-CONTAINING PROTEIN 3 IS A PREDICTOR OF ENDOCRINE THERAPY RESPONSE IN BREAST CANCER Shorouk Makhlouf, UK |
|
Breast Imaging | ||
P02 | RESIDUAL MICROCALCIFICATIONS AFTER NEOADJUVANT SYSTEMIC THERAPY FOR EARLY BREAST CANCER: IMPLICATIONS FOR SURGICAL PLANNING AND LONG-TERM OUTCOMES Joel Allotey, UK |
|
P03 | LOCALIZATION OF NON-PALPABLE BREAST LESIONS Martina Costa, Italy |
|
P04 | DIAGNOSIS OF PRIMARY AND SECONDARY BREAST LYMPHOMA: SOME CASES FROM OUR INSTITUTE AND REVIEW OF THE LITERATURE Martina Costa, Italy |
|
DCIS | ||
P05 | HOW CAN WE PREDICT UPSTAGING TO INVASIVE BREAST CANCER AFTER A BIOPSY DIAGNOSIS OF DUCTAL CARCINOMA IN SITU? Julia Riggi, Belgium |
|
HER2 positive breast cancer | ||
P06 | MAKING OUTCOME-BASED PRICING A REALITY IN THE UK – A RETROSPECTIVE COMPARISON OF COST-BASED VS OUTCOME-BASED PRICING FOR TRASTUZUMAB EMTANSINE (KADCYLA) IN METASTATIC BREAST CANCER Karim El-Shakankery, UK |
|
Locoregional therapy | ||
P07 | IMPACT OF OMITTING ROUTINE INTRAOPERATIVE FROZEN SECTION IN SENTINEL NODE BIOPSY FOR BREAST CANCER Youmna Abdelaziz, UK |
|
P08 | RECONSIDERING THE NEED FOR INTRAOPERATIVE FROZEN SECTION IN SENTINEL LYMPH NODE BIOPSY FOR EARLY BREAST CANCER IN BAHRAIN Hussain Abdulla, Bahrain |
|
P09 | AXILLARY RECURRENCE IN NON-STANDARD VS STANDARD AXILLARY LYMPH NODE DISSECTION IN N2-N3 HER2+ AND TRIPLE NEGATIVE BREAST CANCER PATIENTS THAT UNDERGO NEOADJUVANT SYSTEMIC THERAPY Sergio Aguilar-Villanueva, Mexico |
|
P10 | LOCO-REGIONAL TREATMENT IN METASTATIC BREAST CANCER Emanuela Esposito, Italy |
|
P11 | LONG TERM PATIENT REPORTED OUTCOMES FOLLOWING THERAPEUTIC MAMMAPLASTY OVER 17 YEARS Katherine Fairhurst, UK |
|
P12 | DOES USE OF INTRAOPERATIVE INDOCYANINE GREEN (ICG) IMAGING REDUCE THE RISK OF MASTECTOMY SKIN FLAP NECROSIS (MFN) IN IMMEDIATE DEEP INFERIOR EPIGASTRIC PERFORATOR (DIEP) BREAST RECONSTRUCTIVE SURGERY? Xin Yi Foong, UK |
|
P13 | SURGICAL MANAGEMENT OF THE NODE POSITIVE AXILLA WITH TARGETED AXILLARY DISSECTION IN BREAST CANCER: A SINGLE CENTRE EXPERIENCE OVER 6 YEARS OF PRACTICE Chia Yin Goh, UK |
|
P14 | POST MASTECTOMY RECONSTRUCTION PRACTICES AND OUTCOMES FOR OLDER WOMEN IN A UK TERTIARY CARE CENTRE Junaid Zia Hashmi, UK |
|
P15 | IMPLANT RECONSTRUCTION: TO MESH OR NOT TO MESH? Kate Homyer, UK |
|
P16 | ONCOLOGICAL AND COSMETIC OUTCOMES OF LOCAL PERFORATOR FLAPS IN ONCOPLASTIC BREAST SURGERY; SINGLE CENTRE EXPERIENCE IN UK Huma Irshad, UK |
|
P17 | ARE WE PERFORMING DIFFERENT TYPES OF OPERATION IN OUR OLDER BREAST CANCER PATIENTS COMPARED TO OUR YOUNGER BREAST CANCER PATIENTS? David John, UK |
|
P18 | POST-CHEMOTHERAPY AXILLARY CONSERVATION SURGERY – UTILITY OF PRE-OPERATIVE AXILLARY ULTRASOUND AND INTRA-OPERATIVE FROZEN SECTION Shalaka Joshi, India |
|
P19 | RESULTS OF THE INFLUENCE TRIAL: A STUDY COMPARING INDOCYANINE GREEN (ICG) FLUORESCENCE COMBINED WITH A STANDARD TRACER VERSUS ICG ALONE FOR SENTINEL NODE BIOPSY IN EARLY BREAST CANCER Rahul Kanitkar, UK |
|
P20 | CHEST WALL PERFORATOR BASED FLAPS FOR PARTIAL BREAST RECONSTRUCTION AFTER BREAST CONSERVATION SURGERY: A CASE SERIES Anupama Mane, India |
|
P21 | EXPLORING THE LANDSCAPE OF LOCOREGIONAL THERAPY DE-ESCALATION IN EARLY BREAST CANCER: A SYSTEMATIC REVIEW Stuart Andrew McIntosh, UK |
|
P22 | BORDERLINE PHYLLODES TUMOUR IN 10-YEAR-OLD PREPUBERTAL FEMALE PRESENTING WITH NON-TENDER DISCRETE BREAST LUMP: A CASE REPORT Kathryn McKnight, Ireland |
|
P23 | ONCOLOGICAL OUTCOMES OF LARGE VOLUME PARTIAL BREAST RESECTIONS RECONSTRUCTED WITH LATTISSIMUS DORSI FLAP OR THERAPEUTIC MAMMOPLASTY Ankita Nirpharake, India |
|
P24 | SHOULD WE ADOPT NO CANCER ON INK? AN AUDIT OF MARGIN RE-EXCISION RATES AGAINST ASCO AND ABS GUIDELINES Francesca Peters, UK |
|
P25 | DELAYED POST-BIOPSY TO SURGERY INTERVAL TENDS TO INCREASE AXILLARY NODAL METASTASIS, ESPECIALLY IN EARLY BREAST CANCER PATIENTS Phatcharawan Prasitviset, Thailand |
|
P26 | PIONEERING BREAST CANCER EDUCATION IN EGYPT: INSIGHTS FROM THE FIRST ADVANCED ONCOPLASTIC BREAST SURGERY SKILLS COURSE BY THE EGYPTIAN GROUP OF BREAST SURGEONS Ibrahim Sallam, UK |
|
P27 | ADVANCING BREAST RECONSTRUCTION: LICAP FLAP OPTIMIZATION TO ACHIEVE SUPERIOR NIPPLE AND BREAST SYMMETRY Ibrahim Sallam, UK |
|
P28 | IS COMPLETION AXILLARY NODE CLEARANCE OF ANY VALUE TO GUIDE ADJUVANT TREATMENT CHOICE? OUTCOMES OF AN AUDIT Mahmoud Soliman, UK |
|
P29 | LATE TOXICITY AFTER ADJUVANT WHOLE BREAST ULTRA-HYPOFRACTIONATED RADIOTHERAPY WITH SIB: A MATCHED PAIR ANALYSIS BETWEEN OPEN CAVITY AND ONCOPLASTIC SURGERY Ranjan Subramani, India |
|
P30 | FLUORESCENT-GUIDED SURGERY IN ECTOPIC BREAST SURGERY: NODAL STAGING Alessio Vinci, UK |
|
P31 | RADIATION THERAPY FOR CONTRALATERAL INTERNAL MAMMARY LYPMH NODES Masahiro Yoshida, Japan |
|
Molecular assays | ||
P32 | PREDICTION OF HER2 POSITIVE BREAST CANCER PATIENTS RESPONSE TO ANTI-HER2 THERAPY USING MRNA LEVEL Nehal Atallah, UK |
|
P33 | THE IMPACT OF ONCOTYPE DX TESTING ON ADJUVANT CHEMOTHERAPY DECISION MAKING IN BREAST CANCER WITH SENTINEL LYMPH NODE MICROMETASTASIS Sendhil Rajan, UK |
|
Neoadjuvant therapy | ||
P34 | MANAGEMENT OF A LYMPH NODE POSITIVE AXILLA AFTER NEO-ADJUVANT CHEMOTHERAPY FOR BREAST CANCER: A SINGLE CENTRE EXPERIENCE Khalid Amin, UK |
|
P35 | PATHOLOGICAL COMPLETE RESPONSE RATE AS A PROGNOSTIC FACTOR ACROSS MOLECULAR SUBTYPES OF BREAST CANCER: INSIGHTS FROM REAL WORLD DATA! Mitchelle Engineer, India |
|
P36 | EMERGING TECHNOLOGIES FOR MONITORING BREAST CANCER RESPONSE TO NEOADJUVANT CHEMOTHERAPY: A SCOPING REVIEW Thomas Hubbard, UK |
|
P37 | USING RAMAN SPECTROSCOPY TO DIFFERENTIATE TREATMENT RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER Thomas Hubbard, UK |
|
P38 | NEOADJUVANT ENDOCRINE THERAPY: A SINGLE CENTRE STUDY EXAMINING THE USE OF NEOADJUVANT ENDOCRINE THERAPY IN ER+VE BREAST CANCER PATIENTS Harsimran Kaur Surinder Singh, UK |
|
Precision oncology | ||
P39 | LABEL-FREE IMPEDIMETRIC BIOSENSOR BASED ON DNA CHARACTERIZATION FOR HUMAN SAMPLES WITH BREAST CANCER Leticia Arias, Mexico |
|
P40 | MODULATORS OF RESPONSE TO TRASTUZUMAB-BASED CHEMOTHERAPY IN HER2-POSITIVE BREAST CANCER Nehal Atallah, UK |
|
P41 | HEMATOLOGICAL AND BIOCHEMICAL MARKERS INFLUENCING BREAST CANCER RISK AND MORTALITY: PROSPECTIVE COHORT STUDY IN THE UK BIOBANK BY MULTI-STATE MODELS Xiaoxi Huang, China |
|
P42 | CHARACTERISATION OF PLEOMORPHIC LOBULAR CARCINOMA: AN IMAGE ANALYSIS-ASSISTED STUDY Shorouk Makhlouf, UK |
|
P43 | INTEGRATION OF MULTI-OMICS DATA FOR PERSONALIZED TREATMENT IN TRIPLE-NEGATIVE BREAST CANCER Eugenie Tseuh Tabe, Cameroon |
|
Prevention | ||
P44 | SHOULD WE BE MARKING THE AXILLA WITH DELAYED SENTINEL NODE TRACERS IN RISK REDUCING MASTECTOMIES (RRM)? Youmna Abdelazi, UK |
|
P45 | PATIENT PARTICIPATION IN BRIEF LIFESTYLE INTERVENTION AND UNDERSTANDING OF MODIFIABLE RISKS FACTORS IN BREAST CANCER: AGREEABLE AND EFFECTIVE? Katy Homyer, UK |
|
P46 | A CASE REPORT OF MALE BREAST CANCER 29 YEARS AFTER TOTAL BODY IRRADIATION FOR ACUTE LYMPHOBLASTIC LEUKAEMIA Kezia Summers, UK |
|
Screening | ||
P47 | USE OF A WIRELESS RADAR LOCALISATION DEVICE TO STREAMLINE PATIENT CARE Gauri Babu, UK |
|
P48 | THE IMPACT OF BREAST DENSITY NOTIFICATION ON ANXIETY IN SOUTH AUSTRALIAN WOMEN UNDERGOING BREAST CANCER SCREENING Wendy Ingman, Australia |
|
P49 | REDUCING AXILLARY SURGERY IN ELDERLY PATIENTS WITH SMALL BREAST CANCERS Victor Lim, UK |
|
P50 | LARGE VOLUME EXTENSIVE SAMPLING (LVES) AS FIRST LINE BIOPSY TECHNIQUE IN SELECTED GROUP OF CASES IN BREAST SCREENING PROGRAMME Archana Seth, UK |
|
Symptom management | ||
P51 | ANTIBIOTIC PROPHYLAXIS AGAINST SURGICAL SITE INFECTION FOR ELECTIVE BREAST SURGERY Abdulaziz Alshamlan, Saudi Arabia |
|
P52 | GYNAECOMASTIA REFERRAL PATHWAY – TIME FOR A CHANGE Abdelbari Gdeh, UK |
|
P53 | USAGE OF BRACKETED MAGSEED (TWO OR MORE) FOR BREAST WIDE LOCAL EXCISION IN MULTIFOCAL OR MULTICENTRIC BREAST CANCER (MFBC/MCBC) COMBINED WITH PARTIAL BREAST RECONSTRUCTION USING PERFORATOR FLAPS Akram Girgis, UK |
|
P54 | POSTOPERATIVE COMPLICATIONS FOLLOWING BREAST AUGMENTATION MASTOPEXY SURGERY ABROAD AND ITS IMPACT ON NATIONAL HEALTH SERVICE (CASE REVIEW) Akram Girgis, UK |
|
P55 | IDENTIFYING RESEARCH PRIORITIES FOR IMPROVING INFORMATION AND SUPPORT FOR PATIENTS UNDERGOING BREAST CANCER SURGERY: A UK PATIENT-CENTRED PRIORITY SETTING PARTNERSHIP Stuart McIntosh, UK |
|
Triple negative breast cancer | ||
P56 | NAVIGATING SYNCHRONOUS BREAST AND COLON CANCER: MULTIDISCIPLINARY MANAGEMENT OF LOW ESTROGEN RECEPTOR-POSITIVE TUMOR – A CASE REPORT Farah Bani-Khaled, Jordan |
|
P57 | INFLAMMATORY BREAST CANCER – SINGLE CENTER EXPERIENCE IN BANGLADESH Sadia Siddiky, UK |